FBDS.US Fuss Brands Corp.
- Market cap
- USD 4.29K
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2025.
Is FBDS.US undervalued?
Graham numberThe Graham number of Fuss Brands Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fuss Brands Corp. fundamental analysis
No fundamental analysis for Fuss Brands Corp. yet.
Fuss Brands Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fuss Brands Corp.
Fuss Brands Corp. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022. Fuss Brands Corp. was incorporated in 1988 and is based in New York, New York.
Full company profileFuss Brands Corp. financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jul 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fuss Brands Corp. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 28.0M | 28.0M | 43.4M | 55.2M | 72.7M | - | 72.7M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 14.3M | 14.3M | 23.1M | 29.4M | 43.2M | - | 43.2M | - | - | - | - |
| Operating Income | 9.56M | 9.56M | 14.8M | 17.8M | 29.5M | - | -325K | -107K | -503K | -2.75M | -155K |
| EBITDA | 9.89M | 9.86M | 15.2M | 18.6M | 30.5M | -110M | 88.00 | -107K | -503K | 359.00 | -155K |
| Net Income | 9.60M | 9.60M | 14.8M | 17.9M | 25.9M | -110M | -325K | -107K | -505K | -2.76M | -161K |
| EPS | 7.12 | 7.12 | 11 | 12 | 18 | -77 | -0.23 | -0.01 | -0.03 | -0.14 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 24.9M | 24.9M | 53.2M | 73.1M | 110M | - | 110M | 35.5K | 139K | 228K | 230K |
| Total Liabilities | 3.50M | 3.50M | 2.69M | 3.39M | 10.2M | 10.2M | 31.4K | 99.4K | 588K | 916K | 1.04M |
| Shareholders' Equity | 21.4M | 21.4M | 50.5M | 69.8M | 99.7M | - | -31.4K | -63.9K | -449K | -687K | -808K |
| Cash & Short-term Investments | 10.2M | 10.2M | 8.11M | 27.8M | 15.3M | - | 15.3M | 35.5K | 9.45K | 1.44K | 633.00 |
| Total Debt | - | - | - | - | - | - | 31.4K | 98.4K | 148K | 564K | 683K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.88M | 8.88M | 13.1M | 23.8M | 21.1M | -75.1K | -75.1K | -106K | -99.6K | -423K | -160K |
| Capital Expenditure | 45.7K | 45.7K | 14.8M | 4.70M | 34.7M | 0.00 | 34.7M | 4.00 | 5.00 | 4.00 | 0.00 |
| Free Cash Flow | 8.83M | 8.83M | -1.69M | 19.1M | -13.5M | - | -75.1K | -106K | -99.6K | -423K | -160K |
| Ratios | |||||||||||
| ROE | 44.9% | 44.9% | 29.4% | 25.6% | 26.0% | - | - | - | - | - | - |
| ROA | 38.6% | 38.6% | 27.9% | 24.4% | 23.6% | - | -0.3% | -302.2% | -362.5% | -1,207.4% | -69.9% |
| Net Profit Margin | 34.2% | 34.2% | 34.2% | 32.4% | 35.6% | - | -0.4% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Fuss Brands Corp. dividends
Fuss Brands Corp. has not paid dividends in the last 9 fiscal years.
Last stock split: 1:26 on Jul 22, 2022.
Who owns Fuss Brands Corp.
- Insiders 48.29%
- Institutions 0.00%
- Public & others 51.72%
- Shares outstanding 21.5M
- Free float 11.1M
Fuss Brands Corp. company profile
- Company name
- Fuss Brands Corp.
- Ticker
- FBDS.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 1
- Fiscal year end
- October
- Address
- 80 Broad Street, New York, NY, United States, 10004
- Phone
- 917 720 3366
- Website
- fussbrands.com
About Fuss Brands Corp.
Fuss Brands Corp. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. and changed its name to Fuss Brands Corp. in July 2022. Fuss Brands Corp. was incorporated in 1988 and is based in New York, New York.
Fuss Brands Corp. management
1- Mr. Cheskel MeiselsChairman of the Board, CFO, CEO, Secretary & Treasurer · born 1978